|
Market Closed -
OTC Markets
00:35:41 18/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.1900 USD | -0.21% |
|
-40.62% | -99.84% |
| 11-03 | GlucoTrack, Inc.(OTCPK:GCTK) dropped from S&P TMI Index | CI |
| 10-29 | GlucoTrack, Inc.(OTCPK:GCTK) dropped from NASDAQ Composite Index | CI |
Company Valuation: GlucoTrack, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 70.6 | 63.8 | 21.57 | 5.46 | 5.975 | 3.524 |
| Change | - | -9.63% | -66.19% | -74.69% | 9.44% | -41.02% |
| Enterprise Value (EV) 1 | 61.14 | 57.99 | 19.46 | 1.164 | 0.6255 | -0.4127 |
| Change | - | -5.16% | -66.45% | -94.02% | -46.27% | -165.98% |
| P/E | - | - | - | - | - | -0.12x |
| PBR | - | - | - | - | - | 1.25x |
| PEG | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -19.8x | -14.5x | -4.41x | -0.16x | -0.04x | 0.03x |
| EV / EBIT | -19.5x | -14.4x | -4.39x | -0.16x | -0.04x | 0.03x |
| EV / FCF | -22x | -25.6x | -9.13x | -0.3x | -0.08x | 0.04x |
| FCF Yield | -4.54% | -3.91% | -11% | -335% | -1,326% | 2,289% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | -936.5 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | - | - | - | - |
| EBITDA 1 | -3.085 | -3.998 | -4.409 | -7.091 | -14.51 | -16.05 |
| EBIT 1 | -3.132 | -4.04 | -4.432 | -7.104 | -14.55 | -16.09 |
| Net income 1 | -2.696 | -4.067 | -4.435 | -7.097 | -22.6 | -19.39 |
| Net Debt 1 | -9.46 | -5.812 | -2.117 | -4.296 | -5.35 | -3.937 |
| Reference price 2 | 830,603.6500 | 750,593.9952 | 253,797.9696 | 47,069.6234 | 13,427.9893 | 116.0999 |
| Nbr of stocks (in thousands) | 0.09 | 0.09 | 0.09 | 0.12 | 0.45 | 30.4 |
| Announcement Date | 13/04/21 | 31/03/22 | 31/03/23 | 28/03/24 | 31/03/25 | 30/03/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 225K | ||
| 17.32x | 6.64x | 12.72x | 1.72% | 66.37B | ||
| 32.67x | 8.73x | 28.87x | 0.07% | 58.86B | ||
| 38.41x | 6.84x | 20.46x | 0.85% | 55.22B | ||
| 44.13x | 6.17x | 29.36x | -.--% | 47.21B | ||
| 34.55x | 3.29x | 14.19x | -.--% | 42.45B | ||
| 36.23x | 8.96x | 23.37x | 0.36% | 36.44B | ||
| -19.98x | 53.61x | -21.71x | -.--% | 35.19B | ||
| 41.91x | 8.08x | 27.1x | -.--% | 32.66B | ||
| -74.98x | 14.21x | -76.38x | -.--% | 26.73B | ||
| Average | 16.70x | 12.95x | 6.44x | 0.33% | 40B | |
| Weighted average by Cap. | 21.75x | 11.52x | 11.45x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- GCTK Stock
- Valuation GlucoTrack, Inc.
Select your edition
All financial news and data tailored to specific country editions
















